Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study

Documenti analoghi

• Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics
  di: Martin Parsons, et al.
  Pubblicazione: (2025)
• Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis
  di: Kaiya Hassan, et al.
  Pubblicazione: (2024)
• Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
  di: Luisa Weiss, et al.
  Pubblicazione: (2024)
• Heparin Doped Polyaniline for Anticoagulation Supercapacitors
  di: Yuxia Zhang, et al.
  Pubblicazione: (2025)
• Non‐Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer
  di: S. A. Hamza, et al.
  Pubblicazione: (2025)